期刊文献+

血清Ang/Tie2、VEGF在糖尿病肾病病情评估中的应用价值 被引量:6

Application value of serum Ang/Tie2,VEGF in the assessment of diabetic nephropathy
在线阅读 下载PDF
导出
摘要 目的观察血清中血管生成素-1(Ang-1)、血管生成素-2(Ang-2)及其受体Tie2与血管内皮生长因子(VEGF)在糖尿病肾病(DN)病情进展中的水平变化规律,探讨平衡其比率在DN中的重要性。方法选取2型糖尿病患者60例,依据尿白蛋白排泄率(UAER)分为3组:正常白蛋白尿患者20例(DM1组)、微量白蛋白尿患者22例(DM2组)、大量白蛋白尿患者18例(DM3组),另设健康对照患者22例(NC组)。采用ELISA法检测受试者血清Ang-1、Ang-2、Tie2、VEGF水平,同时检测相关生化指标。结果 1 DM1组血清VEGF、Ang-2水平高于NC组,DM2组、DM3组进一步升高,4组间差异均有统计学意义(P<0.05)。2 DM1组血清Ang-1水平高于NC组,DM2组、DM3组逐渐下降,4组间差异无统计学意义。3 Tie2水平差异无统计学意义。4UAER与Ang-2、VEGF呈正相关性(r=0.470、0.404,P<0.01),与Ang-1呈负相关性(r=-0.310,P<0.05);Ang-2与VEGF、Tie2呈正相关性(r=0.450、0.725,P<0.01);Ang-1与Tie2呈正相关性(r=0.571,P<0.01),与Ang-2、VEGF呈负相关性(r=-0.497、-0.396,P<0.01,P<0.05)。5以UAER为应变量行多元线性逐步回归分析显示:Ang-1、Ang-2、VEGF、肌酐进入回归方程,是影响UAER的独立相关因子。结论血清中Ang-1、Ang-2、Tie2、VEGF水平与DN密切相关,可能参与了DN的发生发展,并影响DN病情的进程。检测血清Ang/Tie2及VEGF可作为评估DN病情的重要指标。 Objective To observe the regular levels change of serum angiopoietin-1 (Ang-1),angiopoietin-2 (Ang-2) and receptor Tie2 as well as vascular endothelia growth factor (VEGF) in the progerssion of diabetic nephropa-thy ( DN) , and investigate the importance of ratio of balance among them in DN. Methods Sixty Chinese patients with type 2 diabetes were enrolled. According to their UAER diabetic patients were divided into three groups ran-domly:20 patients with normoalbuminuric diabetic ( DM1 group) , 22 with microalbuminuric diabetic( DM2 group) and 18 proteinuric diabetic (DM3 group). A total of 22 health contros were selected(NC group). Serum Ang-1, Ang-2,Tie2,VEGF levels were detected by ELISA. At the same time, related biochemical indicators were tested. Results ①The level of serum Ang-2,VEGF increased in DM1 compared with NC, and serum Ang-2,VEGF levels in DM2 and DM3 were much higher. There was statistical difference among four groups (P〈0. 05). ②The level of serum Ang-1 increased in DM1 compared with NC, but serum Ang-1 levels in DM2 and DM3 were much lower.③ There was no statistical significance in difference among the four groups. There was no statistical significance in differences of Tie2 .④ UAER had positive correlation with serum Ang-2 , VEGF ( r =0. 470 , 0. 404 , P 〈0. 01 ) . UAER had negative correlation with serum Ang-1(r= -0. 310,P〈0. 05). Ang-2 had positive correlation with ser-um VEGF,Tie2(r =0. 450,0. 725,P 〈0. 01). Ang-1 had positive correlation with serum Tie2(r =0. 571,P 〈0. 01). Ang-1 had negative correlation with serum Ang-2,VEGF (r= -0. 497,-0. 396,P〈0. 01,P〈0. 05). ⑤Line to UAER level as the dependent variable, multiple stepwise regression analysis showed that: Ang-1,Ang-2, VEGF,creatinine entered regression equation. They were independent correlation factors for UAER. Conclusion Serum Ang-1,Ang-2,Tie2 and VEGF levels are closely related with DN. They may participate in the development of DN and affect the process of DN. Detection of serum Ang/Tie2 and VEGF levels can be used as a reference in-dex for the condition of DN.
出处 《安徽医科大学学报》 CAS 北大核心 2015年第4期508-511,共4页 Acta Universitatis Medicinalis Anhui
基金 广西自然科学基金资助项目(编号:2011GXNSFA018238)
关键词 糖尿病肾病 血管生成素 血管内皮生长因子 TIE2 尿白蛋白排泄率 diabetic nephropathy angiopoietin VEGF Tie2 urinary albumin excretion rate
作者简介 霍亚杰,女,硕士研究生 温玉洁,女,教授,主任医师,硕士生导师,责任作者,E-mail:wenyujie888@qq.com
  • 相关文献

参考文献4

二级参考文献38

  • 1姚毅,关明,赵秀琴,黄一飞.缺氧和高浓度葡萄糖对体外培养人视网膜色素上皮衍生因子表达的影响[J].中华医学杂志,2003,83(22):1989-1992. 被引量:31
  • 2俞雨生,季大玺.终末期糖尿病肾病与透析治疗[J].肾脏病与透析肾移植杂志,2006,15(4):376-379. 被引量:16
  • 3Flyvbjerg A.Putative pathophysiological role of growth factors and cytokines in experimental diabetic kidney disease.Diabetologia,2000;43(10):1205-1223.
  • 4Satchell SC,Mathieson PW.Angiopoietins:microvascular modulators with potential roles in glomerular pathophysiology.J Nephrol,2003;16(2):168-178.
  • 5Abdulmalek K,Ashur F,Ezer N,et al.Differential expression of Tie-2 receptors and angiopoietins in response to in vivo hypoxia in rats.Am J Physiol Lung Cell Mol Physiol,2001;281(3):L582-L590.
  • 6Yamamoto Y,Maeshima Y,Kitayama H,et al.Tumstatin peptide,an inhibitor of angiogenesis,prevents glomerular hypertrophy in the early stage of diabetic nephropathy.Diabetes,2004;53(7):1831-1840.
  • 7Satchell SC,Anderson KL,Mathieson PW,et al.Angiopoietin 1 and vascular endothelial growth factor modulate human glomerular endothelial cell barrier properties.J Am Soc Nephrol,2004;15(3):566-574.
  • 8Khamaisi M,Schrijvers B,de Vriese AS,et al.The emerging role of VEGF in diabetic kidney disease.Nephrol Dial Transplant,2003;18(8):1427-1430.
  • 9Yuan HT,Tipping PG,Li XZ,et al.Angiopoietin correlates with glomerular capillary loss in anti-glomerular basement membrane glomerulonephritis.Kidney Int,2002;61(6):2078-2089.
  • 10Long DA,Woolf AS,Suda T,et al.Increased renal angiopoietin-1 expression in folic acid-induced nephrotoxicity in mice.J Am Soc Nephrol,2001;12(12):2721-2731.

共引文献27

同被引文献72

  • 1Qiao-Ying You,Fu-Yuan Zhuge,Qi-Qian Zhu,Xu-Wei Si.Effects of laser photocoagulation on serum angiopoietin-1, angiopoietin-2, angiopoietin-1/angiopoietin-2 ratio, and soluble angiopoietin receptor Tie-2 levels in type 2 diabetic patients with proliferative diabetic retinopathy[J].International Journal of Ophthalmology(English edition),2014,7(4):648-653. 被引量:9
  • 2Sternlicht H,Bakris GL.Management of hypertension in diabetic nephropathy:how low should we go?[J].Blood Purif,2016,41(1-3):139-143.
  • 3Sweetwyne MT,Gruenwald A,Niranjan T,et al.Notch1and Notch2in podocytes play differential roles during diabetic nephropathy development[J].Diabetes,2015,64(12):4099-4111.
  • 4Aziz KM.Correlation of urine biomarkers:microalbuminuria and spot urine protein among diabetic patients.application of spot urine protein in diabetic kidney disease,nephropathy,proteinuria estimation,diagnosing and monitoring[J].Recent Pat Endocr Metab Immune Drug Discov,2015,9(2):121-133.
  • 5Blaslov K,Bulum T,Duvnjak L.Pathophysiological factors in the development of diabetic nephropathy--new insights[J].Acta Med Croatica,2014,68(2):135-140.
  • 6Koulis C,Chow BS,McKelvey M,et al.AT2Ragonist,compound 21,is reno-protective against type 1diabetic nephropathy[J].Hypertension,2015,65(5):1073-1081.
  • 7Ruilope LM,Agarwal R,Chan JC,et al.Rationale,design,and baseline characteristics of ARTS-DN:a randomized study to assess the safety and efficacy of finerenone in patients with type2 diabetes mellitus and a clinical diagnosis of diabetic nephropathy[J].Am J Nephrol,2014,40(6):572-581.
  • 8Zhao LS,Xu CY.Effect of prazosin on diabetic nephropathy patients with positiveα1-adrenergic receptor autoantibodies and refractory hypertension[J].Exp Ther Med,2015,9(1):177-182.
  • 9Leiria LF,Severo MD,Ledur PS,et al.White coat effect and masked uncontrolled hypertension in treated hypertensive-diabetic patients:Prevalence and target organ damage[J].J Diabetes,2015,7(5):699-707.
  • 10Gangadhariah MH,Luther JM,Garcia V,et al.Hypertension is a major contributor to 20-hydroxyeicosatetraenoic acid-mediated kidney injury indiabetic nephropathy[J].J Am Soc Nephrol,2015,26(3):597-610.

引证文献6

二级引证文献125

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部